ERIS LIFESCIENCES Q2 FY27 (CONS.) ; NET PROFIT UP 39.17% AT ₹187.14 CR (YOY), UP 30.58% (QOQ)

REVENUE UP 12.64% AT ₹892.37 CR (YOY), UP 2.07% (QOQ) EBITDA UP 14.12% AT ₹263.25 CR (YOY), UP 9.45% (QOQ) MARGINS AT 29.50% VS 29.11% (YOY), 27.51% (QOQ)

ERIS LIFESCIENCES LIMITED

← Back to feed